Klozapin Accord (Clozapine)

• Clozapine is an atypical antipsychotic that acts on dopamine and serotonin pathways to treat serious mental health disorders.
• Schizophrenia: reduces positive and negative symptoms and helps prevent relapse in adult patients.
• Treatment‑resistant schizophrenia: provides symptom control when other antipsychotics have failed.
• Schizoaffective disorder: stabilizes mood and psychotic features in patients with mixed symptomatology.

• Clozapine exerts its antipsychotic effect primarily by antagonizing dopamine D2 receptors while simultaneously blocking serotonin 5‑HT2A receptors. This dual activity modulates dopaminergic and serotonergic neurotransmission, leading to a reduction in psychotic symptoms. Additional affinity for receptors such as D4, α‑adrenergic, histamine H1 and muscarinic sites contributes to its unique efficacy profile and side‑effect spectrum.

Clozapine may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects

• Sedation: feeling of drowsiness or fatigue.
• Weight gain: increase in body weight over time.
• Dry mouth: reduced salivation.
• Constipation: decreased bowel movements.

Serious or Rare Side Effects

• Agranulocytosis: severe reduction in white blood cells requiring regular blood monitoring.
• Myocarditis: inflammation of the heart muscle that can be fatal.
• Seizures: risk increases with higher doses.

• Before initiating Clozapine therapy, several safety considerations should be observed.
• Baseline blood count: obtain a complete blood count before starting treatment.
• Regular monitoring: perform weekly white blood cell counts for the first 18 weeks, then monthly.
• Cardiac assessment: evaluate for myocarditis symptoms, especially during early treatment.
• Seizure risk: assess patient history and avoid high doses in those prone to seizures.
• Pregnancy and lactation: use only if benefits outweigh risks; discuss with obstetrician.
• Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Clozapine interacts with several medicines, requiring careful management to avoid adverse outcomes.

Major Interactions (Avoid)

• CYP1A2 inhibitors (e.g., fluvoxamine): can markedly increase Clozapine plasma levels, risking toxicity.
• Concomitant use with other myelosuppressive agents: may exacerbate agranulocytosis.
• Smoking cessation: abrupt cessation can raise Clozapine concentrations, necessitating dose adjustment.

Moderate Interactions (Monitor Closely)

• CYP1A2 inducers (e.g., carbamazepine, smoking): may reduce Clozapine levels, decreasing efficacy.
• Benzodiazepines: may enhance sedation and respiratory depression.
• Anticholinergic drugs: can increase risk of constipation and urinary retention.